Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-17
DOI
10.3389/fphar.2021.750826
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isotschimgine alleviates nonalcoholic steatohepatitis and fibrosis via FXR agonism in mice
- (2021) Junxiao Li et al. PHYTOTHERAPY RESEARCH
- Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditions
- (2021) Alex Zaufel et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases
- (2020) Tarun Belwal et al. Frontiers in Pharmacology
- Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
- (2020) Svenja Sydor et al. Clinical and Translational Gastroenterology
- Effect of gut microbiota and PNPLA3 rs738409 variant on non-alcoholic fatty liver disease (NAFLD) in obese youth
- (2020) Ayesha Monga Kravetz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice
- (2020) Qiong Li et al. JOURNAL OF ETHNOPHARMACOLOGY
- Discovery and Optimization of Non-bile Acid FXR Agonists as Preclinical Candidates for the Treatment of Nonalcoholic Steatohepatitis
- (2020) Junyou Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
- (2020) Yifei Zhang et al. Nature Communications
- FGF15/19 is required for adipose tissue plasticity in response to thermogenic adaptations
- (2020) Samantha Morón-Ros et al. Molecular Metabolism
- Metabolic and Gut Microbial Characterization of Obesity-Prone Mice under a High-Fat Diet
- (2019) Yu Gu et al. JOURNAL OF PROTEOME RESEARCH
- Unexpected Rapid Increase in the Burden of Nonalcoholic Fatty Liver Disease in China From 2008 to 2018: A Systematic Review and Meta‐Analysis
- (2019) Feng Zhou et al. HEPATOLOGY
- Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases
- (2019) Hui-Hui Guo et al. Nature Communications
- Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans
- (2019) Lingyan Wu et al. Cell Death & Disease
- Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease
- (2019) Yiwen Zhang et al. BMC GENOMICS
- NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Stephen A Harrison et al. LANCET
- Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders
- (2018) Maria A. Neag et al. Frontiers in Pharmacology
- Berberine Directly Affects the Gut Microbiota to Promote Intestinal Farnesoid X Receptor Activation
- (2018) Yuan Tian et al. DRUG METABOLISM AND DISPOSITION
- A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis
- (2017) Jurema Schmidt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility
- (2017) Elaine F. Enright et al. MOLECULAR PHARMACEUTICS
- DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model
- (2016) Koichi Achiwa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dose-response effect of berberine on bile acid profile and gut microbiota in mice
- (2016) Ying Guo et al. BMC Complementary and Alternative Medicine
- Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study
- (2016) Zoltan Pataky et al. DIGESTIVE DISEASES AND SCIENCES
- An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
- (2016) Frank J. Gonzalez et al. GASTROENTEROLOGY
- Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
- (2016) Runbin Sun et al. MOLECULAR PHARMACOLOGY
- UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats
- (2016) Xiaojiaoyang Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity
- (2015) Young-Chae Kim et al. HEPATOLOGY
- Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
- (2015) Jiarong Lan et al. JOURNAL OF ETHNOPHARMACOLOGY
- Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
- (2015) Hong-Mei Yan et al. PLoS One
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
- (2014) Akinobu Takaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
- (2013) Fei Li et al. Nature Communications
- DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH
- (2011) Erwin Gäbele et al. JOURNAL OF HEPATOLOGY
- Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
- (2010) Z. M. YOUNOSSI ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of berberine in patients with type 2 diabetes mellitus
- (2008) Jun Yin et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started